Previous 10 | Next 10 |
2023-09-28 12:59:55 ET Gainers: Baudax Bio ( BXRX ) +75% . Chico's Fas ( CHS ) +63% . Aytu BioPharma ( AYTU ) +35% . Axcella Health ( AXLA ) +35% . Vaccinex ( VCNX ) +33% . Organogenesis Holdings ( ORGO ) +27% . F...
2023-09-28 11:55:43 ET What do you consider the best penny stocks ? Are they the ones exploding higher within a single session? Maybe they’re the ones that go on to become market leaders. On the other hand, you could simply be looking for penny stocks to buy and sell this week. I...
Aytu BioPharma, Inc. (NASDAQ: AYTU) is one of today's top gainers. The company's shares are currently up 20.3% on the day to $2.31. Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United...
2023-09-28 10:00:05 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.53...
2023-09-27 19:01:03 ET Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript September 27, 2023, 04:30 PM ET Company Participants Robert Blum - IR Josh Disbrow - CEO Mark Oki - CFO Conference Call Participants Naz Rahman - Maxim Group Pre...
2023-09-27 16:24:03 ET More on Aytu BioScience Seeking Alpha’s Quant Rating on Aytu BioScience Historical earnings data for Aytu BioScience Financial information for Aytu BioScience For further details see: Aytu BioScience GAAP EPS of -$0.59 beats ...
Nabriva Therapeutics plc (NBRVF) is expected to report for Q2 2023 JFE Holdings, Inc. (JFEEF) is expected to report for Q1 2024 Superior Gold Inc (SUPGF) is expected to report for Q2 2023 S&W Seed Company (SANW) is expected to report $-0.09 for Q4 2023 Jefferies Financial Grou...
Aytu BioPharma Inc. (AYTU) is expected to report for Q4 2023
2023-09-26 17:35:39 ET More on Aytu BioScience Seeking Alpha’s Quant Rating on Aytu BioScience Historical earnings data for Aytu BioScience Financial information for Aytu BioScience For further details see: Aytu BioScience FQ4 Earnings Preview
2023-09-26 17:35:05 ET Major earnings expected after the bell on Tuesday include: Micron Technology ( MU ) Jefferies Financial Group ( JEF ) Aytu Biopharma ( AYTU ) Concentric Corporation ( CNXC ) For further details see: Notable earnings after Tu...
News, Short Squeeze, Breakout and More Instantly...
Company receives proceeds of $3.5 million through exercise of warrants, a portion of which was used to pay down debt Interest rate on new $13.0 million term loan reduced by approximately 350 basis points today, potentially saving the Company $1.3 million over the life of the term loan T...
Phoenix, Arizona and New York, New York--(Newsfile Corp. - May 29, 2024) - Lytham Partners, a leading investor relations and corporate access firm, today announced the schedule for its Spring 2024 Investor Conference taking place virtually on May 30, 2024. More than 40 companies will be available...
DENVER, CO / ACCESSWIRE / May 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that Josh Disbrow, CEO, will participate in a webcasted fireside chat and host one-on-one meetings with inv...